[181] DT389 hYP7 scFv HepG2 HCC Decreased cell viability and specific toxicity [182] CTCL: cutaneous T-cell lymphoma; mVEGF: mouse vascular endothelial growth factor; DTAT: DT fused to the amino (N)-terminal of uPA; uPA: urokinase-type plasminogen activator; BPDCN: blastic plasmacytoid ...